USPTO TTABVUE. Trademark Trial and Appeal Board Inquiry System

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

TTABVUE. Trademark Trial and Appeal Board Inquiry System

v2.5.0

Summary

Query: Party Name contains all words: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Number of results: 100+
Results are in reverse chronological order

Proceeding
Filing Date

Defendant(s),
Property(ies)

Plaintiff(s),
Property(ies)

91237303
10/18/2017

Intra-Cellular Therapies, Inc.
Mark: CAPLYRA S#:87334173

Boehringer Ingelheim International GmbH
Mark: SAMLYRA S#:79190967 R#:5111796

87334143
07/20/2017

INTRA-CELLULAR THERAPIES, INC.
Mark: CAMLYRA S#:87334143

Boehringer Ingelheim International GmbH

87334225
07/20/2017

INTRA-CELLULAR THERAPIES, INC.
Mark: CAMLYR S#:87334225

Boehringer Ingelheim International GmbH

87334173
07/20/2017

INTRA-CELLULAR THERAPIES, INC.
Mark: CAPLYRA S#:87334173

Boehringer Ingelheim International GmbH

87406397
07/05/2017

Intarcia Therapeutics, Inc.
Mark: ZIRMANA S#:87406397

Boehringer Ingelheim International GmbH

87113215
12/22/2016

Johnson & Johnson
Mark: ZYNEBZO S#:87113215

Boehringer Ingelheim International GmbH

87047963
11/22/2016

Alkermes Pharma Ireland Limited
Mark: ARLIANCE S#:87047963

Boehringer Ingelheim International GmbH

86641980
10/04/2016

Glaxo Group Limited
Mark: LYPRONTA S#:86641980

Boehringer Ingelheim International GmbH

91229102
07/18/2016

Boehringer Ingelheim International GmbH
Mark: M² MEET SQUARE S#:79173572

Square, Inc.
Mark: SQUARE S#:77798169 R#:3917735
Mark: SQUARE S#:77798170 R#:3962489
Mark: SQUARE S#:85542833 R#:4597599
Mark: SQUARE S#:86144480 R#:4818628
Mark: SQUARE S#:86144464 R#:4717557

86706664
07/20/2016

Raptor Pharmaceuticals Inc.
Mark: AXVYLA S#:86706664

Boehringer Ingelheim International GmbH

91228273
05/31/2016

Boehringer Ingelheim International GmbH
Mark: ONFEXIS S#:79176276

Lundbeck LLC
Mark: ONFI S#:85976587 R#:4162511

91228005
05/10/2016

Novartis AG
Mark: STAZOLVI S#:79175636

Boehringer Ingelheim International GmbH
Mark: STIOLVI S#:79114849 R#:4277863

91227755
05/03/2016

Boehringer Ingelheim International GmbH
Mark: LONZILDA S#:79162762

Lonza Ltd.
Mark: LONZA S#:72346919 R#:956300
Mark: LONZA S#:86138751 R#:4639815
Mark: LONZA S#:79128068 R#:4483125
Mark: LONZABAC S#:78763546 R#:3559042
Mark: LONZABAC S#:76309265 R#:2803019
Mark: LONZAINE S#:73035538 R#:1031102
Mark: LONZEST S#:73677210 R#:1482091
Mark: LONZAMON S#:73838888 R#:1627873
Mark: LONZACURE S#:73744212 R#:1527614

86809460
05/05/2016

ZOGENIX INTERNATIONAL LIMITED
Mark: REYORDA S#:86809460

Boehringer Ingelheim International GmbH

86776755
04/04/2016

Portola Pharmaceuticals, Inc.
Mark: VORXATO S#:86776755

Boehringer Ingelheim International GmbH

79176276
03/31/2016

Boehringer Ingelheim International GmbH
Mark: ONFEXIS S#:79176276

Lundbeck LLC

79176972
02/29/2016

Boehringer Ingelheim International GmbH
Mark: AQIVLA S#:79176972

H. Lundbeck A/S

79173572
02/18/2016

Boehringer Ingelheim International GmbH
Mark: M² MEET SQUARE S#:79173572

Square, Inc.

79175636
02/11/2016

Novartis AG
Mark: STAZOLVI S#:79175636

Boehringer Ingelheim International GmbH

86348518
01/25/2016

Bayer Intellectual Property GmbH
Mark: REASSURE S#:86348518

Boehringer Ingelheim International GmbH

79162762
01/12/2016

Boehringer Ingelheim International GmbH
Mark: LONZILDA S#:79162762

Lonza Ltd.

86663738
11/13/2015

Glaxo Group Limited
Mark: ZINTERIO S#:86663738

Boehringer Ingelheim International GmbH

92061693
06/19/2015

Boehringer Ingelheim International GmbH
Mark: PRAXFAB S#:79132994 R#:4460694
Mark: PRAXDOTA S#:79132993 R#:4460693
Mark: PRAXDOT S#:79129491 R#:4405327

Ferndale IP, Inc.
Mark: PRAX S#:73501842 R#:1353649

92061665
06/11/2015

Boehringer Ingelheim International GmbH
Mark: PRAXBIND S#:79129787 R#:4416606

Ferndale IP, Inc.
Mark: PRAX S#:73501842 R#:1353649

86454602
08/13/2015

Neoceuticals LLC
Mark: PRAXID S#:86454602

Boehringer Ingelheim International GmbH
Ferndale IP, Inc.